CELZ Creative Medical Technology Holdings, Inc. stock chart & analysis
Conviction 45HealthcareScan · Wed, Nov 18, 2026Creative Medical Technology Holdings, Inc. (CELZ) closed at $0.4694 (-1.51%) on Nov 18, 2026. Its latest daily candle is a tweezer bottom. Price is below its 50-day and below its 200-day moving average. RSI(14) 25, RS Rating 4, -90.0% from its 52-week high, -76.0% year to date. Sector: Healthcare · Biological Products, (No Diagnostic Substances).
Why CELZ moved
From the StockSetups movers recaps that covered CELZ, newest first. A recap states what was known that day.
- Premarket+73.2%
No specific company-level catalyst is confirmed. The most relevant recent filing is an S-3 shelf registration filed July 24, followed by a 424B3 resale prospectus on August 3 — both are capital-raising mechanisms.
Premarket Stock Movers — August 6, 2026: Why WYHG, PAVS, ENSC, CELZ & MGRX Are Surging → - Premarket+71.8%
Per Investing.com (June 30), Creative Medical secured $4.5 million through a warrant exercise deal. A warrant exercise means existing warrant holders (investors with the right to buy shares at a preset price) chose to exercise those rights, injecting $4.5 million into the company.
Premarket Stock Movers — July 1, 2026: Why DXF, LHAI, LGCL, CELZ & CANF Are Surging → - Premarket+104.9%
A June 30 Stock Titan headline flags an SEC filing: "[RW] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC Filing." Additionally, an S-1/A amendment (an amended IPO registration statement) was filed on June 26, following an original S-1 on June 25.
Premarket Stock Movers — June 30, 2026: Why JEM, SVRE, CELZ, AVXX & BTCT Are Surging →
Financials as of Wed, Sep 30, 2026 · quarterly.
CELZ technical analysis
Trend
CELZ is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 40.2% below the 50-day ($0.7855) and 68.3% below the 200-day ($1.48). ADX(14) at 43 points to a strong, established trend. It meets 0 of 8 trend-template criteria.
Momentum
RSI(14) is 25, in oversold territory. MACD crossed below its signal line 3 sessions ago. A bullish MACD divergence is in place. Its RS Rating of 4 puts its weighted 12-month performance ahead of about 4% of the US market.
Volume and volatility
Volume on the latest session ran 0.4× its 20-day average. It trades about $54,940 a day on average. ATR(14) is $0.0579, 12.3% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.34) shows distribution.
Key levels
The 52-week range is $0.4607 to $4.72; price is 90.0% below the high and 1.9% above the low. The VWAP anchored at the 52-week high is $1.62, above price.
Performance
CELZ returned -25.4% (1 week), -37.8% (1 month), -63.3% (3 months), -79.3% (6 months), -84.6% (1 year), -76.0% (year to date).
About Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Biological Products, (No Diagnostic Substances) · Listed 2009 · 4 employees
SEC filings
EDGAR filings in CELZ · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.